RXST · NASDAQ
RxSight (RXST) Stock Price & Fundamentals
RxSight (RXST) closed at $389.96 on Oct 9, 2026, up 1.67% from the previous close of $383.56.
Share price, past year
1Y +12.76%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $389.96 |
| Sep 30, 2026 | $383.55 |
| Aug 31, 2026 | $362.55 |
| Jul 31, 2026 | $364.35 |
| Jun 30, 2026 | $327.78 |
| May 29, 2026 | $353.42 |
| Apr 30, 2026 | $334.11 |
| Mar 31, 2026 | $339.26 |
| Feb 27, 2026 | $330.65 |
| Jan 30, 2026 | $337.32 |
| Dec 31, 2025 | $346.67 |
| Nov 28, 2025 | $351.64 |
| Oct 31, 2025 | $357.62 |
Key statistics
- Market cap
- $16.22B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- $121.08M
- Net income (TTM)
- −$46.95M
- Shares outstanding
- 41.6M
- Dividend yield
- —
- 52-week range
- $322.54 – $389.96
RxSight's market cap is $16.22B, based on a share price of $389.96 and 41.6M shares outstanding as of Jun 30, 2026.
Financials
RxSight reported revenue of $134.48M for fiscal 2025, down 3.89% from fiscal 2024.
RxSight reported a net loss of $38.94M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $134.48M | −3.9% | −$38.94M | −29.0% | −$0.95 | −$19.34M |
| FY2024ended Dec 31, 2024 | $139.93M | +57.1% | −$27.46M | −19.6% | −$0.71 | −$22.39M |
| FY2023ended Dec 31, 2023 | $89.08M | +81.8% | −$48.61M | −54.6% | −$1.41 | −$46.41M |
| FY2022ended Dec 31, 2022 | $49.01M | +116.9% | −$66.76M | −136.2% | −$2.41 | −$61.24M |
| FY2021ended Dec 31, 2021 | $22.59M | +53.9% | −$48.69M | −215.5% | −$3.57 | −$46.65M |
| FY2020ended Dec 31, 2020 | $14.68M | — | $27.58M | 187.9% | $0.15 | −$37.74M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $27.24M | −$12.10M | −$0.29 |
| Q1 FY2026ended Mar 31, 2026 | $30.89M | −$15.88M | −$0.38 |
| Q4 FY2025ended Dec 31, 2025 | $32.61M | −$9.15M | — |
| Q3 FY2025ended Sep 30, 2025 | $30.34M | −$9.82M | −$0.24 |
| Q2 FY2025ended Jun 30, 2025 | $33.64M | −$11.79M | −$0.29 |
| Q1 FY2025ended Mar 31, 2025 | $37.90M | −$8.19M | −$0.20 |
| Q4 FY2024ended Dec 31, 2024 | $40.21M | −$5.94M | — |
| Q3 FY2024ended Sep 30, 2024 | $35.31M | −$6.34M | −$0.16 |
Company profile
- Name
- RxSight, Inc.
- Ticker
- RXST
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Ophthalmic Goods
- Headquarters
- 100 Columbia Street, Suite 120, Aliso Viejo, CA 92656
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001111485
Recent SEC filings
- Aug 5, 2026
- Aug 5, 2026
- Jul 15, 2026
- Jul 6, 2026
- Jul 6, 2026
- Jun 16, 2026
- May 6, 2026
- May 6, 2026
Frequently asked questions
What is RxSight's stock price?
RxSight (RXST) closed at $389.96 on Oct 9, 2026, up 1.67% from the previous close of $383.56.
What is RxSight's market cap?
RxSight's market cap is $16.22B, based on a share price of $389.96 and 41.6M shares outstanding as of Jun 30, 2026.
How much revenue does RxSight make?
RxSight reported revenue of $134.48M for fiscal 2025, down 3.89% from fiscal 2024.
Does RxSight pay a dividend?
RxSight's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from RxSight, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures